Research graph
References from Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined 18 F-Flotufolastat PSMA PET and mpMRI. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Incidence and prevention strategies for postprostate biopsy infections in the United States from 2012 to 2021
10.1016/j.urolonc.2025.05.005 · 2025 · External reference
10.1016/j.eururo.2019.02.033
10.1016/j.eururo.2019.02.033 · External reference
Unresolved reference
External reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer: 2024 update. Part I: screening, diagnosis, and local treatment with curative intent
10.1016/j.eururo.2024.03.027 · 2024 · External reference
10.1016/s0140-6736(16)32401-1
10.1016/s0140-6736(16)32401-1 · External reference
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
10.1186/s13550-021-00818-2 · 2021 · External reference
10.1016/j.eururo.2021.08.002
10.1016/j.eururo.2021.08.002 · External reference
Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography
10.1016/j.eururo.2021.11.019 · 2022 · External reference
10.2967/jnumed.120.254516
10.2967/jnumed.120.254516 · External reference
10.2967/jnumed.121.263448
10.2967/jnumed.121.263448 · External reference
10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3 · External reference
10.2307/2531595
10.2307/2531595 · External reference
Combined prostate-specific membrane antigen positron emission tomography and multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer
10.1016/j.euo.2025.04.017 · 2025 · External reference
Fluorine-18-labelled prostate-specific membrane antigen positron emission tomography/computed tomography or magnetic resonance imaging to diagnose and localise prostate cancer. a prospective single-arm paired comparison (PEDAL)
10.1016/j.euo.2024.01.002 · 2024 · External reference
Combined utility of 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography and multiparametric magnetic resonance imaging in predicting prostate biopsy pathology
10.1016/j.euo.2021.02.006 · 2022 · External reference
Diagnostic performance of 68Ga prostate-specific membrane antigen PET/MRI compared with multiparametric MRI for detecting clinically significant prostate cancer
10.1148/radiol.2021204093 · 2021 · External reference
Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis
10.1016/j.eururo.2019.06.023 · 2020 · External reference
Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer
10.1097/ju.0000000000004010 · 2024 · External reference
10.2967/jnumed.123.266164
10.2967/jnumed.123.266164 · External reference
